470 related articles for article (PubMed ID: 20545618)
1. Fresh platinum complexes with promising antitumor activity.
Wang X
Anticancer Agents Med Chem; 2010 Jun; 10(5):396-411. PubMed ID: 20545618
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in platinum-based chemotherapeutics that exhibit inhibitory and targeted mechanisms of action.
Khoury A; Deo KM; Aldrich-Wright JR
J Inorg Biochem; 2020 Jun; 207():111070. PubMed ID: 32299045
[TBL] [Abstract][Full Text] [Related]
3. Platinum-based drugs: past, present and future.
Dilruba S; Kalayda GV
Cancer Chemother Pharmacol; 2016 Jun; 77(6):1103-24. PubMed ID: 26886018
[TBL] [Abstract][Full Text] [Related]
4. Preclinical and clinical studies on the use of platinum complexes for breast cancer treatment.
Ott I; Gust R
Anticancer Agents Med Chem; 2007 Jan; 7(1):95-110. PubMed ID: 17266507
[TBL] [Abstract][Full Text] [Related]
5. Trans-platinum complexes in cancer therapy.
Coluccia M; Natile G
Anticancer Agents Med Chem; 2007 Jan; 7(1):111-23. PubMed ID: 17266508
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic studies on the reactions of platinum(II) complexes with nitrogen- and sulfur-donor biomolecules.
Bugarčić ŽD; Bogojeski J; Petrović B; Hochreuther S; van Eldik R
Dalton Trans; 2012 Oct; 41(40):12329-45. PubMed ID: 22890549
[TBL] [Abstract][Full Text] [Related]
7. The rational design of anticancer platinum complexes: the importance of the structure-activity relationship.
Montaña AM; Batalla C
Curr Med Chem; 2009; 16(18):2235-60. PubMed ID: 19519389
[TBL] [Abstract][Full Text] [Related]
8. Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile.
Park GY; Wilson JJ; Song Y; Lippard SJ
Proc Natl Acad Sci U S A; 2012 Jul; 109(30):11987-92. PubMed ID: 22773807
[TBL] [Abstract][Full Text] [Related]
9. Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance.
Kelland LR; Sharp SY; O'Neill CF; Raynaud FI; Beale PJ; Judson IR
J Inorg Biochem; 1999 Oct; 77(1-2):111-5. PubMed ID: 10626362
[TBL] [Abstract][Full Text] [Related]
10. Research progress in modern structure of platinum complexes.
Bai L; Gao C; Liu Q; Yu C; Zhang Z; Cai L; Yang B; Qian Y; Yang J; Liao X
Eur J Med Chem; 2017 Nov; 140():349-382. PubMed ID: 28985575
[TBL] [Abstract][Full Text] [Related]
11. Recent Developments in the Field of Anticancer Platinum Complexes.
Galanski MS
Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):285-95. PubMed ID: 18221042
[TBL] [Abstract][Full Text] [Related]
12. Monofunctional and higher-valent platinum anticancer agents.
Johnstone TC; Wilson JJ; Lippard SJ
Inorg Chem; 2013 Nov; 52(21):12234-49. PubMed ID: 23738524
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A
J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864
[TBL] [Abstract][Full Text] [Related]
14. Ruthenium(II) and Platinum(II) Complexes with Biologically Active Aminoflavone Ligands Exhibit In Vitro Anticancer Activity.
Fabijańska M; Kasprzak MM; Ochocki J
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299199
[TBL] [Abstract][Full Text] [Related]
15. Targeting drug delivery system for platinum(Ⅳ)-Based antitumor complexes.
Zhong Y; Jia C; Zhang X; Liao X; Yang B; Cong Y; Pu S; Gao C
Eur J Med Chem; 2020 May; 194():112229. PubMed ID: 32222677
[TBL] [Abstract][Full Text] [Related]
16. The influence of the ethane-1,2-diamine ligand on the activity of a monofunctional platinum complex.
Graziotto ME; Akerfeldt MC; Gunn AP; Yang K; Somerville MV; Coleman NV; Roberts BR; Hambley TW; New EJ
J Inorg Biochem; 2017 Dec; 177():328-334. PubMed ID: 28789807
[TBL] [Abstract][Full Text] [Related]
17. [Drug discovery research in in-vivo antitumor-active azolato-bridged dinuclear Pt(II) complexes].
Komeda S
Yakugaku Zasshi; 2012; 132(3):253-9. PubMed ID: 22382827
[TBL] [Abstract][Full Text] [Related]
18. A monofunctional trinuclear platinum complex with steric hindrance demonstrates strong cytotoxicity against tumor cells.
Wu S; Wang X; He Y; Zhu Z; Zhu C; Guo Z
J Inorg Biochem; 2014 Oct; 139():77-84. PubMed ID: 24991692
[TBL] [Abstract][Full Text] [Related]
19. Photoactivatable platinum complexes.
Bednarski PJ; Mackay FS; Sadler PJ
Anticancer Agents Med Chem; 2007 Jan; 7(1):75-93. PubMed ID: 17266506
[TBL] [Abstract][Full Text] [Related]
20. New platinum antitumor complexes.
Kelland LR
Crit Rev Oncol Hematol; 1993 Dec; 15(3):191-219. PubMed ID: 8142057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
